6533b82efe1ef96bd129326a
RESEARCH PRODUCT
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
Hans-heinrich WolfManfred BinderGabriele IhorstJohannes BloehdornMartina DeckertBenjamin KasendaAnke MorgnerJohannes AttaUlrich KellerJuergen FinkePeter HauKristina FritschAlexander RöthCarsten HirtGerald IllerhausNorbert FrickhofenLöw SJens PanseRalph NaumannHeß GStephanie SasseUwe M. MartensStefan W. KrauseClaudia HaderMonika LamprechtHeidi FrickerElisabeth SchorbRobert Möhlesubject
MaleCancer Researchmedicine.medical_specialtyLymphomaPopulationMedizinProcarbazineGastroenterologyCentral Nervous System Neoplasms03 medical and health sciences0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansImmunologic FactorseducationAgedNeoplasm StagingProportional Hazards ModelsAged 80 and overeducation.field_of_studyHematologybusiness.industryRemission InductionPrimary central nervous system lymphomaHematologyLomustinemedicine.diseaseSurgeryTumor BurdenMethotrexateTreatment OutcomeOncology030220 oncology & carcinogenesisCytarabineQuality of LifeMethotrexateRituximabOriginal ArticleFemalebusiness030215 immunologymedicine.drugdescription
Leukemia : normal and malignant hemopoiesis 31(4), 846-852 (2017). doi:10.1038/leu.2016.334
year | journal | country | edition | language |
---|---|---|---|---|
2017-01-01 | Leukemia |